These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 6135774

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effect of lipophilicity of substituted benzamides on the dopaminergic effects in vivo and in vitro.
    Hall H, Ogren SO, Florvall L.
    Acta Pharmacol Toxicol (Copenh); 1984 Sep; 55(3):211-5. PubMed ID: 6542298
    [Abstract] [Full Text] [Related]

  • 23. Dopamine D2 receptors and dopamine metabolism. Relationship between biochemical and behavioural effects of substituted benzamide drugs.
    Magnusson O, Fowler CJ, Köhler C, Ogren SO.
    Neuropharmacology; 1986 Feb; 25(2):187-97. PubMed ID: 2939362
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Dopaminergic mechanisms in the teleost retina. I. Dopamine-sensitive adenylate cyclase in homogenates of carp retina; effects of agonists, antagonists, and ergots.
    Watling KJ, Dowling JE.
    J Neurochem; 1981 Feb; 36(2):559-68. PubMed ID: 6109764
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effects of remoxipride and some related new substituted salicylamides on rat brain receptors.
    Hall H, Sällemark M, Jerning E.
    Acta Pharmacol Toxicol (Copenh); 1986 Jan; 58(1):61-70. PubMed ID: 2869639
    [Abstract] [Full Text] [Related]

  • 29. A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs.
    Jenner P, Elliott PN, Clow A, Reavill C, Marsden CD.
    J Pharm Pharmacol; 1978 Jan; 30(1):46-8. PubMed ID: 22724
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivity.
    Jenner P, Hall MD, Murugaiah K, Rupniak N, Theodorou A, Marsden CD.
    Biochem Pharmacol; 1982 Feb 01; 31(3):325-8. PubMed ID: 7200363
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Biochemical and pharmacological differentiation of neuroleptic effect on dopamine D-1 and D-2 receptors.
    Hyttel J, Christensen AV.
    J Neural Transm Suppl; 1983 Feb 01; 18():157-64. PubMed ID: 6135740
    [Abstract] [Full Text] [Related]

  • 36. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
    Chipkin RE, Iorio LC, Coffin VL, McQuade RD, Berger JG, Barnett A.
    J Pharmacol Exp Ther; 1988 Dec 01; 247(3):1093-102. PubMed ID: 2905002
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effects of pertussis toxin on D2-dopamine receptor in rat striatum: evidence for coupling of Ni regulatory protein with D2-receptor.
    Fujita N, Nakahiro M, Fukuchi I, Saito K, Yoshida H.
    Brain Res; 1985 May 06; 333(2):231-6. PubMed ID: 3158374
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.